Prevalence of anemia before and after initiation of antiretroviral therapy among HIV infected patients at Black Lion Specialized Hospital, Addis Ababa, Ethiopia: a cross sectional study

Table 4 Anemia and its associated factors after ART initiation in HIV positive patients attending Black Lion Specialized Hospital, Addis Ababa, Ethiopia, 2017

Variables	Anemia	Non anemic	X²	P value	AOR (95% CI)
Age(in years)
<30	7 (21.2%)	26 (78.8%)	6.23	0.05	4.01 (1.24–13.02)
30–40	15 (13.3%)	98 (86.7%)			2.25 (0.84–5.98)
>40	7 (6.4%)	102 (93.6%)			1.00
Sex
Male	10 (9.3%)	97 (90.7%)	1.19	0.28	0.79 (0.34–1.85)
Female	19 (12.8%)	129 (87.2%)			1.00
ART regimen
TDF based	21 (11.4%)	164 (88.6%)	0.000	0.99	0.99 (0.40–2.46)
AZT based	8 (11.4%)	62 (88.6%)			1.00
Cotrimoxazole
NO	9 (8.9%)	92 (91.1)	1.01	0.32	0.74 (0.29–1.86)
Yes	20 (13%)	134 (87)			1.00
CD4 count (cells/mm³)
<200	10 (16.2%)	52 (83.9%)	2.62	0.27	2.04 (0.70–5.96)
200–349	10 (12.2%)	72 (87.8%)			1.44 (0.52–3.99)
≥350	9 (8.1%)	102 (91.9%)			1.00
BMI(Kg/m²)
<18.5	4 (12.9%)	27 (87.1%)	0.08	0.96	0.81 (0.21–3.17
18.5–24.9	18 (11.2%)	143 (88.8%)			0.76 (0.29–2.01)
≥25	7 (11.1%)	56 (88.9%)			1.00

AOR Adjusted odds ratio, BMI Body mass index, CI Confidence interval, 1.00 = reference group

ISSN: 2052-1839